PharmaTher Holdings
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
82 Richmond Street East, Toronto, Ontari...Phone Number
(888) 846-3171Website
www.pharmather.comRevenue
<$5 MillionStock Symbol
PHRM.CNIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About PharmaTher Holdings
PharmaTher Holdings Ltd. is a specialty pharmaceutical company focused on developing, acquiring, and commercializing psychedelic pharmaceuticals, including KETARX (ketamine) and other innovative products. The company also offers enabling technologies such as KetAImine AI and KetaVault. Their target clients include healthcare providers and patients seeking advanced therapeutic options. PharmaTher is committed to advancing the field of psychedelic medicine while ensuring safety and efficacy through rigorous research and development.Explore more
PharmaTher Holdings Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PharmaTher Holdings your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on PharmaTher Holdings recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at PharmaTher Holdings
Funding: Get notified immidiatlly once PharmaTher Holdings has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PharmaTher Holdings had a recent Job posting/layoffs
Check if PharmaTher Holdings has recently received funding, and reach out quickly before it becomes old news!
PharmaTher Holdings, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when PharmaTher Holdings launches new products
Check out if PharmaTher Holdings is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined PharmaTher Holdings as Masked Content
Find 2 more new buyers
Compare Similar Companies to PharmaTher Holdings
Compare insights from companies similar to PharmaTher Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PharmaTher Holdings is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PharmaTher Holdings is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PharmaTher Holdings.
PharmaTher Holdings Tech Stack
A closer look at the technologies used by PharmaTher Holdings
See more technologies
PharmaTher Holdings News & Media
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitive Asset Purchase Agreement (the “Agreement”) for the sale of its Abbreviated New Drug Application (ANDA #217858) for Ketamine Hydrochloride Injection USP to a well-established global pharmaceutical company specializPharmaTher Provides Corporate Update Following FDA Approval of Ketamine (KETARx™)
Company advancing U.S. commercialization with FDA-approved ketamine and rare disorder NDA filings Company advancing U.S. commercialization with FDA-approved ketamine and rare disorder NDA filingsPharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx™)
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today that Fabio Chianelli, the Company’s Founder, Chairman and Chief Executive Officer, has issued the following letter to shareholders.Third time lucky as PharmaTher gets FDA approval for ketamine
The ketamine product is the first to be approved in an analgesic setting by the US regulator.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding PharmaTher Holdings
Sign Up For FreeTo access detailed company insights
PharmaTher Holdings Ltd. is a specialty pharmaceutical company focused on developing, acquiring, and commercializing psychedelic pharmaceuticals, including KETARX (ketamine) and other innovative products. The company also offers enabling technologies such as KetAImine AI and KetaVault. Their target clients include healthcare providers and patients... Read More
